Dasatinib + quercetin + fisetin

1 paper

PubChem 3062316 PubChem 5280343 PubChem 5281614 ChEBI 49375 ChEBI 16243 ChEBI 42567

Human trial1

Latest

9 in 12 months

Ageing Research Reviews8 Oct

Is there a role for senotherapeutics in the treatment of giant cell arteritis?

ReviewInterventions

Clinical Interventions in Aging24 Sep

Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review

ReviewMultimorbidity

Frontiers in Endocrinology8 Sep

Senescent immune cells, inflammaging, and bone loss: therapeutic potential and translational challenges of senolytics in osteoporosis

ReviewSenolytics

Frontiers in Oncology22 Aug

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions

ReviewMechanisms

Figshare30 Mar

Augmenting the Cheung Glutamatergic Regimen with a Senescence-Modulator Arm: Mechanistic Rationale for NMN, Intermittent Senolytics, and N-Acetylcysteine in Treatment-Resistant Depression

Preprint: commentarySenolytics

Ageing Research Reviews22 Jan

Evaluating senescence-targeted approaches in Alzheimer's Disease: What we know and what lies ahead

ReviewAlzheimer's disease

AAIC 2025 Abstract24 Dec

Head‐to‐head comparison of two senolytic therapies in a mouse model of tauopathy

Experiments in miceSenolytics

AAIC 2025 Abstract23 Dec

The Dual Role of Tau in Neuroprotection and Disease: Neuronal Senescence as a Therapeutic Target

Non-randomised trial in peopleInterventions

Molecular Neurobiology6 Dec

Senolytics as Modulators of Critical Signaling Pathways: a Promising Strategy to Combat Brain Aging and Neurodegenerative Disorders

ReviewSenolytics

International Journal of Molecular Sciences16 Oct

Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases

ReviewCellular senescence